Goldman Sachs’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,236
| Closed | -$51.3K | – | 5115 |
|
|
2023
Q1 | $51.3K | Sell |
12,236
-16,986
| -58% | -$71.2K | ﹤0.01% | 4762 |
|
|
2022
Q4 | $124K | Buy |
+29,222
| New | +$124K | ﹤0.01% | 4626 |
|
|
2020
Q4 | – | Sell |
-150,000
| Closed | -$1.62M | – | 4744 |
|
|
2020
Q3 | $1.62M | Hold |
150,000
| – | – | ﹤0.01% | 3021 |
|
|
2020
Q2 | $1.61M | Hold |
150,000
| – | – | ﹤0.01% | 2951 |
|
|
2020
Q1 | $1.58M | Hold |
150,000
| – | – | ﹤0.01% | 2886 |
|
|
2019
Q4 | $1.57M | Hold |
150,000
| – | – | ﹤0.01% | 3072 |
|
|
2019
Q3 | $1.55M | Hold |
150,000
| – | – | ﹤0.01% | 2979 |
|
|
2019
Q2 | $1.53M | Hold |
150,000
| – | – | ﹤0.01% | 2939 |
|
|
2019
Q1 | $1.51M | Hold |
150,000
| – | – | ﹤0.01% | 3067 |
|
|
2018
Q4 | $1.47M | Buy |
+150,000
| New | +$1.47M | ﹤0.01% | 2948 |
|